Dr. Michael C. Kim, M.D
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 217
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Georgetown University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NY license 201284
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Lenox Hill Hospital New York, NY
- Eisenhower Medical Center Rancho Mirage, CA
Medical groups
- North Shore-Lij Medical PC (6,440 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 217
- Services billed
- 776
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 239 | 219 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 158 | 155 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 127 | 99 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 57 | 56 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 55 | 52 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 36 | 35 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 30 | 29 |
| Established patient office or other outpatient visit, 30-39 minutes | 16 | 13 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | 15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Manhasset, NY | 52 |
| Atorvastatin Calcium Other prescribers in Manhasset, NY | 51 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Manhasset, NY | 37 |
| Amlodipine Besylate Other prescribers in Manhasset, NY | 19 |
| Lisinopril Other prescribers in Manhasset, NY | 14 |
| Hydrochlorothiazide Other prescribers in Manhasset, NY | 13 |
| Carvedilol Other prescribers in Manhasset, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 52 payments worth $26,126 in total to this clinician.
| Medtronic, Inc. | $22,782 |
|---|---|
| Spectrawave, Inc | $1,197 |
| Boston Scientific Corporation | $426 |
| Philips North America LLC | $269 |
| Cordis US Corp. | $251 |
| Cathworks, Inc. | $249 |
| Abbott Laboratories | $232 |
| Recor Medical Inc | $180 |
| Compensation for services other than consulting (speaking, faculty) | $22,500 |
|---|---|
| Food and Beverage | $3,626 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $4,050 |
| Medtronic, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,700 |
| Medtronic, Inc. Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,700 |
| Medtronic, Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,250 |
| Medtronic, Inc. Jul 17, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,250 |
| Medtronic, Inc. Jul 17, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,250 |
| Medtronic, Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,250 |
| Medtronic, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $2,250 |
| Medtronic, Inc. Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) FFRANGIO · Fractional Flow Reserve (FFR) Systems | $1,800 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 4 companies. The companies reported $676,167 in research payments for these studies, mostly to the institutions running them.
- ALL-RISE
Cathworks, Inc. - Prospective, Multicenter, Single-Arm IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD Duo Study)
Shockwave Medical, Inc - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456 - Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study)
Shockwave Medical, Inc - Clinical Evaluation of the SpectraWAVE X1-FFR Software
Spectrawave, Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.